Oraya Therapeutics
About:
Oraya Therapeutics develops non-invasive robotically-controlled treatments for inflammatory and neovascular diseases of the eye.
Website: http://www.orayainc.com
Twitter/X: zeiss_group
Top Investors: Scale Venture Partners, Domain Associates, Essex Woodlands Healthcare Partners, Synergy Life Science Partner
Description:
Oraya Therapeutics is currently testing its first application of the IRay system. Oraya Therapeutics develops noninvasive robotically controlled treatments for inflammatory and neovascular diseases of the eye.
Total Funding Amount:
$97.3M
Headquarters Location:
Newark, California, United States
Founded Date:
2007-01-01
Contact Email:
info(AT)orayainc.com
Founders:
Michael Gertner
Number of Employees:
51-100
Last Funding Date:
2014-08-05
IPO Status:
Private
Industries:
© 2025 bioDAO.ai